Abilify Asimtufii (Aripiprazole Injection)
Also Known As / Brand Names
Abilify Asimtufii is a long-acting injectable form of aripiprazole. Other related brand names include:
- Abilify Maintena
- Aripiprazole LAI
- Abilify Asimtufii (US Brand)
Product Introduction
Abilify Asimtufii is an extended-release injectable suspension that delivers a monthly dose of aripiprazole. It is administered by a healthcare provider and is used in the treatment of schizophrenia and bipolar I disorder to improve medication adherence and prevent relapse.
Uses of Abilify Asimtufii
- Schizophrenia in adults
- Maintenance treatment of Bipolar I disorder
- Alternative for patients who have trouble adhering to oral antipsychotics
Benefits of Abilify Asimtufii
Abilify Asimtufii offers consistent medication levels through monthly injections, reducing the risk of missed doses. It is especially useful for patients with difficulty in maintaining daily oral medication routines. The long-acting formulation helps control psychotic and mood symptoms more effectively over time.
Side Effects of Abilify Asimtufii
- Weight gain
- Restlessness (akathisia)
- Anxiety
- Insomnia
- Injection site pain
- Dizziness
- Fatigue
- Blurred vision
- Nausea or vomiting
Safety Advice
| Condition | Advice |
|---|---|
| Pregnancy | Caution – Use only if prescribed. Risk-benefit must be evaluated by your doctor. |
| Breastfeeding | SAFE IF PRESCRIBED – Can be used under doctor’s guidance during breastfeeding. |
| Driving | UNSAFE – May cause drowsiness, dizziness or visual disturbances. Avoid driving if affected. |
| Kidney | SAFE – No dose adjustment typically needed for kidney disease. Monitor if severe condition exists. |
| Liver | SAFE – Usually well-tolerated, but patients with severe liver disease should be closely monitored. |